Kinnate Biopharma

Kinnate Biopharma is an American biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors for treating genomically defined cancers. Kinnate Biopharma was founded in 2018 and is headquartered in San Diego, California.
Kinnate Biopharma stock price chart
vol.
change
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential

Kinnate Biopharma balance sheet

Report period2018 2019 2020 2021 2022
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Kinnate Biopharma cash flows

Report period2018 2019 2020 2021 2022
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS

Kinnate Biopharma multipliers

Report period2018 2019 2020 2021 2022
P/E
E/P
P/B
P/S
P/FCF
L/A
Net Debt/EBITDA
EV/EBITDA

Kinnate Biopharma profitability

Report period2018 2019 2020 2021 2022
ROA
ROE
ROS
Kinnate Biopharma assets
Kinnate Biopharma cash flows

Kinnate Biopharma dividend policy

The company doesn't provide dividend

Kinnate Biopharma shares

TickerNameTypeNominal valueISINPrice
KNTE:USKinnate BiopharmaCommon share-US49705R1059$2.65
Kinnate Biopharma news
10.11.2021
Kinnate Biopharma's GAAP loss for 9M 2021 was $63.604 million, up 2.9 times from $22.054 million in the previous year.
Source: {source} pictogram investors.kinnate.com
Pictogram next
All Kinnate Biopharma news
General information
Company nameKinnate Biopharma
SectorHealth Care / Pharmaceuticals, Biotechnology & Life Sciences / Biotechnology / Biotechnology
Business address11975 El Camino Real Suite 101 San Diego, CA 92130 United States
Mailing address11975 El Camino Real Suite 101 San Diego, CA 92130 United States
Websiteinvestors.kinnate.com
Information disclosurewww.sec.gov